In FXS lymphoblastoid cells, sodium valproate has been demonstrated to moderately affect histone modifications at the FMR1 locus, but it does not impact DNA methylation nor significantly influence transcriptional reactivation (Warren, 2007; Tabolacci et al., 2008). This evidence concerns the gene FMR1 and fragile X syndrome.